Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
Huanwen Wu, Shiwei Guo, Xiaoding Liu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

The role of aberrant DNA methylation in cancer initiation and clinical impacts
Franziska Geissler, Ksenija Nesic, Olga Kondrashova, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 19
Early detection of pancreatic cancer by liquid biopsy “PANLIPSY”: a french nation-wide study project
Thomas Bardol, Antoine M. Dujon, Valérie Taly, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Screening for pancreatic cancer has the potential to save lives, but is it practical?
Benjamin L. Mazer, Jae W. Lee, Nicholas J. Roberts, et al.
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 6, pp. 555-574
Open Access | Times Cited: 14
Circulating cell‐free DNA methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma
Guochao Zhao, Ruijingfang Jiang, Yongyong Shi, et al.
Molecular Oncology (2024) Vol. 18, Iss. 11, pp. 2801-2813
Open Access | Times Cited: 4
Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosis
Wenzhe Hu, Xudong Zhao, Nan Luo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
To Predict the Prognosis and Immunological Characteristics of Pancreatic Cancer Based on Disulfide-Death Gene Death-Related lncRNA
Zhihong Liao, Tianxing Dai, F.T. Yuan, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 924-924
Open Access
Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review
Ronit Juthani, Ashish Manne
Frontiers in Oncology (2025) Vol. 15
Open Access
Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review
Elena Ramírez‐Maldonado, Sandra López Gordo, Rui Pedro Major Branco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1640-1640
Open Access | Times Cited: 3
Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics
Xiaohan Shi, Shiwei Guo, Qiaonan Duan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA
Hong-Sik Kim, Jinah Chu, In‐Gu Do, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer
Wei Guo, Peiyao Ying, Ruiyang Ma, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 73, pp. 69-77
Closed Access | Times Cited: 6
Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000
Jin Sun, Ming‐Yang Su, Jianhua Ma, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Circulating tumor DNA: current implementation issues and future challenges for clinical utility
Qilin Hu, Lüjun Chen, Kerui Li, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 62, Iss. 11, pp. 2094-2110
Closed Access | Times Cited: 4
Methylation haplotypes of the insulin gene promoter in children and adolescents with type 1 diabetes: Can a dimensionality reduction approach predict the disease?
Eleni P. Kotanidou, Alexandra Kosvyra, Konstantina Mouzaki, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 1
Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer
Wanpeng Xin, Shu‐Ju Tu, Siqing Yi, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer
Wanpeng Xin, Shu‐Ju Tu, Siqing Yi, et al.
Gene (2023) Vol. 897, pp. 148078-148078
Open Access | Times Cited: 1
Early Detection of Pancreatic Cancer: Considerable Advances, but Still a Long Way to Go
Ruiyuan Xu, Chengcheng Wang, Yupei Zhao
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 672-673
Open Access
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease
Kathleen R. Bartemes, Benjamin R. Gochanour, David M. Routman, et al.
Oral Oncology (2023) Vol. 146, pp. 106568-106568
Open Access
Reply
Samuel Levy, Anna Bergamaschi
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 673-674
Closed Access
A DNA methylation haplotype block landscape in human tissues and preimplantation embryos reveals regulatory elements defined by comethylation patterns
Yan Feng, Zhiqiang Zhang, Yuyang Hong, et al.
Genome Research (2023) Vol. 33, Iss. 12, pp. 2041-2052
Open Access
Page 1

Scroll to top